Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2011

Open Access 01-10-2011 | Research article

A new category of autoinflammatory disease associated with NOD2 gene mutations

Authors: Qingping Yao, Lan Zhou, Philip Cusumano, Nilanjana Bose, Melissa Piliang, Bijal Jayakar, Le-Chu Su, Bo Shen

Published in: Arthritis Research & Therapy | Issue 5/2011

Login to get access

Abstract

Introduction

Autoinflammatory diseases are characterized by seemingly unprovoked episodes of inflammation, without high titers of autoantibodies or antigen-specific T cells, and derive from genetic variants of the innate immune system. This study characterized a cohort of patients with similar phenotypes and nucleotide oligomerization domain 2 (NOD2) gene mutations.

Methods

Diagnostically challenging patients with the following clinical and genetic characteristics were prospectively studied between January 2009 and April 2011: periodic fever, dermatitis, polyarthritis, serositis, negative serum autoantibodies and additional positive NOD2 IVS8+158 gene mutation. Genetic testing for gene mutations of NOD2, tumor necrosis factor receptor-associated periodic fever syndrome (TRAPS) and familial Mediterranean fever (FMF) was performed.

Results

All seven patients with the disease were Caucasians, with four being male. The mean age at disease onset was 40.7 years and disease duration was 3.2 years. These patients characteristically presented with periodic fever, dermatitis and inflammatory polyarthritis. There were gastrointestinal symptoms in three patients, granulomas of the skin and gut in two, and recurrent chest pain in two, with one having pleuritis and pericarditis. Three patients had sicca-like symptoms. Five patients had increased acute phase reactants. All seven patients had negative tests for autoantibodies but carried the NOD2 gene mutation IVS8+158 with four having concurrent R702W mutation.

Conclusions

Our cohort may represent a new disease category of autoinflammatory disease with characteristic clinical phenotypes and genotypes. It may somewhat resemble pediatric Blau's syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Masters SL, Simon A, Aksentijevich I, Kastner DL: Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009, 27: 621-668. 10.1146/annurev.immunol.25.022106.141627.PubMedCentralCrossRefPubMed Masters SL, Simon A, Aksentijevich I, Kastner DL: Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009, 27: 621-668. 10.1146/annurev.immunol.25.022106.141627.PubMedCentralCrossRefPubMed
2.
go back to reference Kastner DL, Aksentijevich I, Goldbach-Mansky R: Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010, 140: 784-790. 10.1016/j.cell.2010.03.002.PubMedCentralCrossRefPubMed Kastner DL, Aksentijevich I, Goldbach-Mansky R: Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010, 140: 784-790. 10.1016/j.cell.2010.03.002.PubMedCentralCrossRefPubMed
3.
go back to reference Blau EB: Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985, 107: 689-693. 10.1016/S0022-3476(85)80394-2.CrossRefPubMed Blau EB: Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985, 107: 689-693. 10.1016/S0022-3476(85)80394-2.CrossRefPubMed
4.
go back to reference James DG: A comparison of Blau's syndrome and sarcoidosis. Sarcoidosis. 1994, 11: 100-101.PubMed James DG: A comparison of Blau's syndrome and sarcoidosis. Sarcoidosis. 1994, 11: 100-101.PubMed
5.
go back to reference Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, De Marchi M, Peserico A: Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev. 2009, 8: 228-232. 10.1016/j.autrev.2008.07.034.CrossRefPubMed Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, De Marchi M, Peserico A: Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev. 2009, 8: 228-232. 10.1016/j.autrev.2008.07.034.CrossRefPubMed
6.
go back to reference Rose CD, Arostegui JI, Martin TM, Espada G, Scalzi L, Yague J, Rosenbaum JT, Modesto C, Cristina Arnal M, Merino R, Garcia-Consuegra J, Carballo Silva MA, Wouters CH: NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009, 60: 1797-1803. 10.1002/art.24533.PubMedCentralCrossRefPubMed Rose CD, Arostegui JI, Martin TM, Espada G, Scalzi L, Yague J, Rosenbaum JT, Modesto C, Cristina Arnal M, Merino R, Garcia-Consuegra J, Carballo Silva MA, Wouters CH: NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009, 60: 1797-1803. 10.1002/art.24533.PubMedCentralCrossRefPubMed
8.
go back to reference Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N: Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003, 110: 2040-2044. 10.1016/S0161-6420(03)00717-6.CrossRefPubMed Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N: Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003, 110: 2040-2044. 10.1016/S0161-6420(03)00717-6.CrossRefPubMed
9.
go back to reference Rose CD, Martin TM: Caspase recruitment domain 15 mutations and rheumatic diseases. Curr Opin Rheumatol. 2005, 17: 579-585. 10.1097/01.bor.0000169362.61443.52.CrossRefPubMed Rose CD, Martin TM: Caspase recruitment domain 15 mutations and rheumatic diseases. Curr Opin Rheumatol. 2005, 17: 579-585. 10.1097/01.bor.0000169362.61443.52.CrossRefPubMed
10.
go back to reference Hawryluk EB, Izikson L, English JC: Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions. Am J Clin Dermatol. 2010, 11: 171-181. 10.2165/11530080-000000000-00000.CrossRefPubMed Hawryluk EB, Izikson L, English JC: Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions. Am J Clin Dermatol. 2010, 11: 171-181. 10.2165/11530080-000000000-00000.CrossRefPubMed
11.
go back to reference McGovern DP, van Heel DA, Ahmad T, Jewell DP: NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut. 2001, 49: 752-754. 10.1136/gut.49.6.752.PubMedCentralCrossRefPubMed McGovern DP, van Heel DA, Ahmad T, Jewell DP: NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut. 2001, 49: 752-754. 10.1136/gut.49.6.752.PubMedCentralCrossRefPubMed
12.
go back to reference Ince AT, Hatirnaz O, Ovunc O, Ozbek U: 1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci. 2008, 53: 1683-1692. 10.1007/s10620-007-0054-4.CrossRefPubMed Ince AT, Hatirnaz O, Ovunc O, Ozbek U: 1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci. 2008, 53: 1683-1692. 10.1007/s10620-007-0054-4.CrossRefPubMed
13.
go back to reference Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP: CARD15 mutations in Blau syndrome. Nat Genet. 2001, 29: 19-20. 10.1038/ng720.CrossRefPubMed Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP: CARD15 mutations in Blau syndrome. Nat Genet. 2001, 29: 19-20. 10.1038/ng720.CrossRefPubMed
14.
go back to reference Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T: Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009, 60: 242-250. 10.1002/art.24134.CrossRefPubMed Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T: Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009, 60: 242-250. 10.1002/art.24134.CrossRefPubMed
16.
go back to reference Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel-Ghodsian N, Targan SR, Rotter JI, Yang H: A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet. 2003, 72: 509-518. 10.1086/367848.PubMedCentralCrossRefPubMed Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel-Ghodsian N, Targan SR, Rotter JI, Yang H: A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet. 2003, 72: 509-518. 10.1086/367848.PubMedCentralCrossRefPubMed
17.
go back to reference Tukel T, Shalata A, Present D, Rachmilewitz D, Mayer L, Grant D, Risch N, Desnick RJ: Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet. 2004, 74: 623-636. 10.1086/382226.PubMedCentralCrossRefPubMed Tukel T, Shalata A, Present D, Rachmilewitz D, Mayer L, Grant D, Risch N, Desnick RJ: Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet. 2004, 74: 623-636. 10.1086/382226.PubMedCentralCrossRefPubMed
18.
go back to reference Karban A, Eliakim R: Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population. Gastroenterology. 2004, 126: 624-625. 10.1053/j.gastro.2003.12.026.CrossRefPubMed Karban A, Eliakim R: Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population. Gastroenterology. 2004, 126: 624-625. 10.1053/j.gastro.2003.12.026.CrossRefPubMed
19.
go back to reference Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F: NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol. 2010, 134: 251-261. 10.1016/j.clim.2009.05.005.CrossRefPubMed Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F: NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol. 2010, 134: 251-261. 10.1016/j.clim.2009.05.005.CrossRefPubMed
Metadata
Title
A new category of autoinflammatory disease associated with NOD2 gene mutations
Authors
Qingping Yao
Lan Zhou
Philip Cusumano
Nilanjana Bose
Melissa Piliang
Bijal Jayakar
Le-Chu Su
Bo Shen
Publication date
01-10-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3462

Other articles of this Issue 5/2011

Arthritis Research & Therapy 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.